Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression

References

• Bade BC, Dela CCS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24. doi:10.1016/j.ccm.2019.10.00132008623
   PubMed Web of Science ®Google Scholar
• Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun. 2019;39(1):22. doi:10.1186/s40880-019-0368-6
   PubMed Web of Science ®Google Scholar
• Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463–473. doi:10.1016/j.mcna.2018.12.00630955514
   PubMed Web of Science ®Google Scholar
• Bagcchi S. Lung cancer survival only increases by a small amount despite recent treatment advances. Lancet Respir Med. 2017;5(3):169. doi:10.1016/S2213-2600(17)30041-3
   PubMed Web of Science ®Google Scholar
• Pagliarini V, Naro C, Sette C. Splicing regulation: a molecular device to enhance cancer cell adaptation. Biomed Res Int. 2015;2015:543067. doi:10.1155/2015/54306726273627
   PubMed Web of Science ®Google Scholar
• Rapa I, Votta A, Giorcelli J, et al. Proposal of a panel of genes identified by miRNA profiling as candidate prognostic biomarkers in lung carcinoids. Neuroendocrinology. 2021;111(1–2):115–122. doi:10.1159/00050640132040954
   PubMed Web of Science ®Google Scholar
• Godin-Heymann N, Brabetz S, Murillo MM, et al. Tumour-suppression function of KLF12 through regulation of anoikis. Oncogene. 2016;35(25):3324–3334. doi:10.1038/onc.2015.39426455320
   PubMed Web of Science ®Google Scholar
• Ding L, Ding Y, Kong X, et al. Dysregulation of Krüppel-like factor 12 in the development of endometrial cancer. Gynecol Oncol. 2019;152(1):177–184.30482501
   PubMed Web of Science ®Google Scholar
• Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol. 2014;51(4):759–774. doi:10.1177/030098581350282024045890
   PubMed Web of Science ®Google Scholar
• Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4(3):143–159. doi:10.1002/emmm.20110020922351564
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dong Y, Hua J, et al. A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis. Gene. 2019;699:125–134. doi:10.1016/j.gene.2019.02.05830849543
   PubMed Web of Science ®Google Scholar
• Halvorsen AR, Sandhu V, Sprauten M, et al. Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab. Acta Oncol. 2018;57(9):1225–1231. doi:10.1080/0284186X.2018.146558529683761
   PubMed Web of Science ®Google Scholar
• Martinez-Gutierrez AD, Cantú de León D, Millan-Catalan O, et al. Identification of miRNA master regulators in breast cancer. Cells. 2020;9(7). doi:10.3390/cells9071610
   PubMed Web of Science ®Google Scholar
• Zhou H, Chen L, Qin M, et al. An miRNA signature associated with tumor mutation burden in endometrial cancer. Biosci Rep. 2020;40(11):BSR20203398.33141168
   PubMed Web of Science ®Google Scholar
• Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018;8(1):9227. doi:10.1038/s41598-018-27521-y29907753
   PubMed Web of Science ®Google Scholar
• Mao S, Lu Z, Zheng S, et al. Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer. J Exp Clin Cancer Res. 2020;39(1):193. doi:10.1186/s13046-020-01680-132958011
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–285. doi:10.1097/JTO.0b013e318206a22121252716
   PubMed Web of Science ®Google Scholar
• Cai M, Shao W, Yu H, Hong Y, Shi L. Paeonol inhibits cell proliferation, migration and invasion and induces apoptosis in hepatocellular carcinoma by regulating miR-21-5p/KLF6 axis. Cancer Manag Res. 2020;6:5931–5943. doi:10.2147/CMAR.S254485
   Web of Science ®Google Scholar
• Lu K, Han W, Lu K. Identification of key microRNAs involved in tumorigenesis and prognostic microRNAs in breast cancer. Math Biosci Eng. 2020;17(4):2923–2935. doi:10.3934/mbe.202016432987507
   PubMed Web of Science ®Google Scholar
• Lu M, Kong X, Wang H, Huang G, Ye C, He Z. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget. 2017;8(5):8775–8784. doi:10.18632/oncotarget.1445228060739
   PubMedGoogle Scholar
• Zhang J, Chong CC, Chen GG, Lai PB. A seven-microRNA expression signature predicts survival in hepatocellular carcinoma. PLoS One. 2015;10(6):e0128628. doi:10.1371/journal.pone.012862826046780
   PubMed Web of Science ®Google Scholar
• Qin L, Huang J, Wang G, et al. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma. J Cell Physiol. 2019;234(12):23581–23595. doi:10.1002/jcp.2892731210353
   PubMed Web of Science ®Google Scholar
• Chen W, Gao C, Liu Y, Wen Y, Hong X, Huang Z. Bioinformatics analysis of prognostic miRNA signature and potential critical genes in colon cancer. Front Genet. 2020;11:478.32582275
   PubMed Web of Science ®Google Scholar
• Kim JS, Chun SH, Park S, et al. Identification of novel microRNA prognostic markers using cascaded Wx, a neural network-based framework, in lung adenocarcinoma patients. Cancers. 2020;12(7):1890.
   PubMed Web of Science ®Google Scholar
• Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9(2):117. doi:10.1038/s41419-017-0063-y29371589
   PubMed Web of Science ®Google Scholar
• Peng LN, Deng XY, Gan XX, et al. Targeting of TLE3 by miR-3677 in human breast cancer promotes cell proliferation, migration and invasion. Oncol Lett. 2020;19(2):1409–1417. doi:10.3892/ol.2019.1124132002031
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou Y, Ma L, Liu D, Dai Z, Shen J. miR-3677-3p promotes hepatocellular carcinoma progression via inhibiting GSK3β. Acta Biochim Biophys Sin. 2020;52(12):1404–1412. doi:10.1093/abbs/gmaa12533200777
   PubMedGoogle Scholar
• Yao B, Li Y, Niu Y, et al. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5. J Cell Mol Med. 2020;24(15):8718–8731. doi:10.1111/jcmm.1550332596968
   PubMed Web of Science ®Google Scholar
• Yu N, Yong S, Kim HK, et al. Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor–normal samples in lung adenocarcinoma. Mol Oncol. 2019;13(6):1356–1368. doi:10.1002/1878-0261.1247830913346
   PubMed Web of Science ®Google Scholar
• Arias N, Aguirre L, Fernández-Quintela A, et al. MicroRNAs involved in the browning process of adipocytes. J Physiol Biochem. 2016;72(3):463–473. doi:10.1007/s13105-015-0459-z
   Web of Science ®Google Scholar
• Yao C, Ruan JW, Zhu YR, et al. The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells. Aging. 2020;12(6):5399–5410. doi:10.18632/aging.10296132203055
   PubMedGoogle Scholar
• He Z, Guo X, Tian S, et al. MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12. J Exp Clin Cancer Res. 2019;38(1):126. doi:10.1186/s13046-019-1105-330866999
   PubMed Web of Science ®Google Scholar
• Mak CS, Yung MM, Hui LM, et al. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis. Mol Cancer. 2017;16(1):11. doi:10.1186/s12943-017-0582-228095864
   PubMed Web of Science ®Google Scholar
• Jia C, Zhang Y, Xie Y, et al. miR-200a-3p plays tumor suppressor roles in gastric cancer cells by targeting KLF12. Artif Cells Nanomed Biotechnol. 2019;47(1):3697–3703. doi:10.1080/21691401.2019.159485731500453
   PubMed Web of Science ®Google Scholar